Tag pharmaceutical development

Key Metrics (historical comparisons) Metric Q1 2025 Q1 2024 Change Change (%) Net Loss (USD) $2,369,232 $1,069,744 +$1,299,488 121.5% Basic EPS (USD) -0.67 -1.68 +1.01 ~60.1% improvement Cash & Cash Equivalents (USD) $3,724,527 $6,759,77 -3,370,250 -49.8% Total Assets (USD) $11,650,794…